NASDAQ · Biotechnology
BeyondSpring Inc (BYSI)
$0.33
-24.49%
37
In band
Moving averages
SMA 200$1.24-73.39%
Company profile
BeyondSpring Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in New York, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$26.47M
P/E ratioNone
EPS$-0.18
Beta-0.132
Dividend yield0.00%
52-week high$2.44
52-week low$0.42
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
BCTX
BriaCell Therapeutics Corp - New
RSI 44
GOVX
Geovax Labs Inc
RSI 17
KTTA
Pasithea Therapeutics Corp
RSI 53
CRBU
Caribou Biosciences Inc
RSI 22
BCDA
BioCardia Inc
RSI 34
IBIO
iBio Inc
RSI 52
RSI alerts for BYSI
An email when BYSI closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:47 AM EST